Skip to main content
Sun Pharma Q1 Results: Taro Troubles In U.S. Cause Over Rs 1,600-Crore Loss - BloombergQuint 01-Aug-2020
Sun Pharma Q1 Results: Taro Troubles In U.S. Cause Over Rs 1,600-Crore Loss - BloombergQuint
Sun Pharma provided a sum of Rs 3,176 crore to settle Taro Pharma’s generic drug price-fixing allegations in the U.S.
More...